Every material Form 8-K Ingredion filed with the SEC in 2025, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Ingredion reported third-quarter 2025 results with diluted EPS of $2.61, down from $2.83 a year earlier, and adjusted EPS of $2.75 versus $3.05. Net sales fell 3% to $1.8 billion and reported operating income fell 7% to $249 million, with a Chicago plant production problem weighing on its U.S./Canada segment. The company also updated its full-year 2025 outlook, now expecting reported EPS of $11.11 to $11.31, which matters to shareholders because weaker quarterly profit and sales are the key measures they track.
Q3 2025 diluted EPS $2.61 vs $2.83 in Q3 2024; adjusted EPS $2.75 vs $3.05
Q3 net sales $1.816 billion, down 3%; reported operating income $249 million, down 7%
Full-year 2025 guidance: reported EPS $11.11 to $11.31; adjusted EPS $11.10 to $11.30
Net sales now expected flat to down low single digits; operating income up low to mid single digits
Ingredion entered into a new five-year, $1.0 billion unsecured revolving credit facility dated August 27, 2025, with JPMorgan Chase Bank, N.A. and J.P. Morgan SE as administrative agent. The new agreement replaced the company's previous facility from June 30, 2021, which was terminated on the same date; that facility would otherwise have matured June 30, 2026. No loans had been drawn under the new facility as of its effective date, so it adds borrowing capacity rather than new debt.
Five-year unsecured revolving facility of $1.0 billion, maturing August 27, 2030
No loans drawn as of the effective date; up to $750 million of incremental commitments may be requested
Covenants require a maximum leverage ratio of 3.5 to 1.0 and minimum interest coverage of 3.5 to 1.0
Previous credit agreement dated June 30, 2021 was terminated August 27, 2025
Ingredion reported second-quarter 2025 diluted EPS of $2.99, up from $2.22 a year earlier, and adjusted EPS of $2.87, flat year over year. Net sales fell 2% to $1.83 billion, while the company raised its full-year 2025 reported EPS guidance to $11.25 to $11.75 and adjusted EPS guidance to $11.10 to $11.60.
Q2 2025 net sales were $1.83 billion, down 2% from $1.88 billion a year earlier.
Q2 operating income rose 13% to $271 million; adjusted operating income was $273 million, up 1%.
Full-year 2025 reported EPS guidance is $11.25 to $11.75, and adjusted EPS guidance is $11.10 to $11.60.
The company cited a mechanical fire that briefly shut down its Chicago plant as a negative factor in the F&II U.S./Canada segment.
Ingredion reported first-quarter 2025 results with net sales down 4% to $1,813 million, while reported operating income rose 30% to $276 million. Reported diluted EPS fell to $3.00 from $3.23, but adjusted EPS rose to $2.97 from $2.08, and the company raised its full-year 2025 reported and adjusted EPS ranges.
Net sales fell 4% to $1,813 million; reported operating income rose 30% to $276 million
Reported diluted EPS was $3.00 versus $3.23 a year earlier; adjusted diluted EPS was $2.97 versus $2.08
Full-year 2025 reported EPS guidance is $10.93 to $11.63; adjusted EPS guidance is $10.90 to $11.60
Second-quarter 2025 operating income is expected to be flat to down low single-digits
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Ingredion filing is on SEC EDGAR ↗. 8-K briefs of other companies →